Leap Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 220.4%.

Top 25 shareholders own 49.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.9%	Gilead Sciences, Inc.	5,319,148	US$13.7m	0%	no data
8.1%	Balyasny Asset Management L.P.	3,100,000	US$8.0m	362%	0.02%
6.38%	Samsara BioCapital LLC	2,442,352	US$6.3m	265%	1.3%
3.06%	Baker Bros. Advisors LP	1,172,175	US$3.0m	0%	0.04%
2.38%	Rock Springs Capital Management LP	911,937	US$2.3m	9.48%	0.07%
2.27%	The Vanguard Group, Inc.	867,708	US$2.2m	112%	no data
1.92%	BeiGene, Ltd.	734,844	US$1.9m	0%	no data
1.86%	Citadel Advisors LLC	711,319	US$1.8m	4.18%	no data
1.77%	HealthCare Ventures LLC	676,320	US$1.7m	0%	100.0%
1.25%	Adage Capital Management, L.P.	480,000	US$1.2m	-49.1%	no data
1.18%	683 Capital Management, LLC	450,000	US$1.2m	0%	0.12%
0.98%	Simplify Asset Management Inc.	375,976	US$966.3k	0%	0.09%
0.93%	Acuta Capital Partners, LLC	354,166	US$910.2k	0%	0.71%
0.74%	Acadian Asset Management LLC	282,413	US$725.8k	349%	no data
0.61%	Key Client Fiduciary Advisors, LLC	233,018	US$598.9k	8.58%	0.32%
0.53%	Geode Capital Management, LLC	202,572	US$520.6k	-0.68%	no data
0.3%	Renaissance Technologies LLC	114,470	US$294.2k	692%	no data
0.3%	Knott Partners Management, LLC	114,355	US$293.9k	1,040%	0.1%
0.28%	UBS O'Connor LLC	107,412	US$276.0k	-25.2%	0.02%
0.19%	Douglas Onsi	73,646	US$189.3k	0%	no data
0.17%	Dimensional Fund Advisors LP	65,617	US$168.6k	0%	no data
0.17%	State Street Global Advisors, Inc.	63,213	US$162.5k	0%	no data
0.14%	HANSAINVEST Hanseatische Investment-GmbH	54,000	US$138.8k	0%	0.01%
0.12%	Northern Trust Global Investments	45,215	US$116.2k	1.47%	no data
0.1%	Logos Global Management, L.P.	39,500	US$101.5k	0%	0.01%